TL;DR: Panacea is a Y Combinator Spring 2026 startup AI-Native FDA Regulatory Services, currently active with a team of 2.
AI-Native FDA Regulatory Services
Last verified:
Panacea provides AI-native FDA regulatory services for Biotechs and Medical Device companies. We hire the most experienced FDA consultants in the industry (ex-FDA, decades of experience, hundreds of filings) and pair them with our AI platform to enable the fastest and lowest cost pathway to FDA approval. While other regulatory consultants bill hourly, our pricing model is simple: fixed, outcome-based pricing. Payment is only due when milestones are complete. We support all FDA regulatory pathways including IND, NDA, BLA, ODD, Pre-Subs, 510(k), De Novo, PMA, IDE, BDD, etc.
Yes. Panacea was funded by Y Combinator in the Spring 2026 batch. AI-Native FDA Regulatory Services
Panacea provides AI-native FDA regulatory services for Biotechs and Medical Device companies. We hire the most experienced FDA consultants in the industry (ex-FDA, decades of experience, hundreds of filings) and pair them with our AI platform to enable the fastest and lowest cost pathway to FDA approval. While other r…
Panacea was part of Y Combinator's Spring 2026 batch.
Panacea has a team of 2 people according to Y Combinator's directory.
Panacea is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…